Triple Point Biologics Inc is a biotechnology and pharmaceutical startup founded in 2003. The company specializes in producing and marketing antibodies and purified proteins for exploring the role of MMPs and TIMPs in various pathological conditions. With a focus on the biotechnology and pharmaceutical industries, TPB aims to leverage its expertise to make significant contributions to understanding and addressing natural pathological conditions.
There is no investment information
No recent news or press coverage available for Triple Point Biologics Inc.